 Statins activate phosphatidylinositol-3-kinase, activates ecto-5'-nucleotidase phosphorylates 3-phosphoinositide-dependent kinase-1 (PDK-1). Phosphorylated (P-)PDK-1 phosphorylates Akt, phosphorylates endothelial nitric oxide synthase (eNOS). asked blockade adenosine receptors (A(1), A(2A), A(2B), A(3) receptors) could attenuate induction Akt eNOS atorvastatin (ATV) whether ERK1/2 involved ATV regulation Akt eNOS. protocol 1, mice received intraperitoneal ATV, theophylline (TH), ATV + TH, vehicle. protocol 2, mice received intraperitoneal injections ATV, U0126 (an ERK1/2 inhibitor), ATV + U0126, vehicle; 8 h later, hearts assessed immunoblot analysis. protocol 3, mice received intraperitoneal ATV alone 8-sulfophenyltheophylline (SPT); 1, 3, 6 h injection, hearts assessed immunoblot analysis. protocol 4, mice received intraperitoneal ATV alone SPT, 1,3-dipropyl-8-cyclopentylxanthine (DPCPX), 1,3,7-trimethyl-8-(3-chlorostyryl)xanthine (CSC), alloxazine, MRS-1523; 3 h injection, hearts assessed immunoblot analysis. ATV increased P-ERK, P-PDK-1, Ser(473) P-Akt, Thr(308) P-Akt, P-eNOS levels. TH blocked ATV-induced increases P-ERK, Ser(473) P-Akt, Thr(308) P-Akt, P-eNOS levels without affecting induction P-PDK-1 ATV. U0126 blocked ATV induction Ser(473) P-Akt Thr(308) P-Akt attenuating induction P-eNOS. detectable increase P-ERK, Ser(473) P-Akt P-eNOS seen 3 6 h injection 1 h. DPCPX, CSC, alloxazine partially blocked ATV induction P-ERK, Ser(473) P-Akt, P-eNOS. conclusion, blockade adenosine A(1), A(2A), A(2B) receptors A(3) receptors inhibited induction Akt eNOS statins. Adenosine required ERK1/2 activation statins, resulted Akt eNOS phosphorylation.